Revolution Medicines Inc. Common Stock vs Veeva Systems — how do they compare? Revolution Medicines Inc. Common Stock trades at $191.91 (market cap $40.32B), while Veeva Systems trades at $291.31 (market cap $46.12B). The key difference: Revolution Medicines Inc. Common Stock and Veeva Systems are close in size by market cap, and Veeva Systems is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| RVMD | VEEV | |
|---|---|---|
Market Cap | $40.32B | $46.12B |
Volume | 4,855,734 | 921,537 |
Sector | Health | Technology |
52-Week High | $221.15 | $299.10 |
52-Week Low | $47.50 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $37.02B | $39.03B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →